Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
Vascular closure device dev Cardiva Medical said yesterday it closed a $30 million round of equity financing to support the commercial expansion of its Vascade vascular closure system.
The round was joined by affiliates of Luther King Capital Management with participation from existing major investors, including PTV Healthcare Capital and Canepa Advanced Healthcare Fund, the Santa Clara, Calif.-based company said. Read more
Corindus Vascular Robotics said today it inked a partnership deal with WakeMed Health & Hospitals.
Through the deal, the groups will develop a center which aims to advance clinical robotics research and train interventional cardiologists on robotic-assisted percutaneous coronary interventions using its CorPath GRX system, the Waltham, Mass.-based company said. Read more
InVivo Therapeutics said today it won approval to commence clinical trials in the UK from the Medicines Healthcare Products Regulatory Agency.
The Cambridge, Mass.-based company said it is in late-stage conversation with various clinical sites in the UK to join the Inspire study of its neuro-spinal scaffold, with a hopeful 1st opening “in the coming weeks.” Approval of the trial is still dependent on approval from the Research Ethics Committee and from the Health Regulatory Approval. Read more
Johnson & Johnson’s Ethicon subsidiary may close a Scottish surgical suture manufacturing plant, taking 400 jobs with it, according to a BBC report.
The decision to close the Livingston, Scotland plant was part of the company’s global restructuring plans, which were announced las January, according to J&J’s medical device division. Read more
Alere said today it will be unable to file its annual 10-K report by its extended March 16 deadline due to an investigation of inappropriate conduct at its South Korean Standard Diagnostics subsidiary.
The Waltham, Mass.-based company filed for the extension on March 1 after it missed its initial reporting date, allegedly due to issues with how it recognized revenues in Asia. Read more